HeartWare International Inc Sets New 1-Year High at $100.90 (HTWR)
HeartWare International (NASDAQ:HTWR) set a new 52-week high during trading hours on Tuesday, Analyst Ratings Network.com reports. The company traded as high as $100.90 and last traded at $100.62, with a volume of 179,785 shares. The stock had previously closed at $99.04.
Several analysts have recently commented on the stock. Analysts at JPMorgan Chase & Co. raised their price target on shares of HeartWare International from $125.00 to $131.00 in a research note to investors on Monday, December 16th. Separately, analysts at Canaccord Genuity raised their price target on shares of HeartWare International from $110.00 to $115.00 in a research note to investors on Tuesday, December 3rd. Finally, analysts at CRT Capital initiated coverage on shares of HeartWare International in a research note to investors on Tuesday, November 26th. They set a “buy” rating and a $109.00 price target on the stock. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $98.58.
In other HeartWare International news, Insider Jeffrey Larose sold 15,342 shares of HeartWare International stock on the open market in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $100.00, for a total value of $1,534,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
HeartWare International has a 52 week low of $69.31 and a 52 week high of $99.68. The stock’s 50-day moving average is $93.15 and its 200-day moving average is $85.6. The company’s market cap is $1.650 billion.
HeartWare International (NASDAQ:HTWR) last released its earnings data on Thursday, November 7th. The company reported ($0.69) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.14. The company had revenue of $54.80 million for the quarter, compared to the consensus estimate of $49.40 million. Analysts expect that HeartWare International will post $-3.11 EPS for the current fiscal year.
Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.